Garry A Nicholson G1 Therapeutics, Inc. (GTHX) insider trading activity

Garry A Nicholson is of G1 Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GTHX, which is worth approximately $0. The most recent transaction as insider was on Sep 18, 2024, when has been sold 14,389 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Garry A Nicholson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 18 2024	SELL Disposition due to a tender of shares in a change of control transaction	-	14,389 Reduced 100.0%	0 Common Stock
Sep 18 2024	SELL Sale (or disposition) back to the issuer	-	20,000 Reduced 58.16%	14,389 Common Stock
Jun 13 2024	BUY Grant, award, or other acquisition	-	10,000 Added 22.53%	34,389 Common Stock
Jun 15 2023	BUY Grant, award, or other acquisition	-	10,000 Added 29.08%	24,389 Common Stock
Jun 23 2022	BUY Grant, award, or other acquisition	-	10,000 Added 41.0%	14,389 Common Stock
Jun 17 2021	BUY Grant, award, or other acquisition	-	4,389 Added 50.0%	4,389 Common Stock

Also insider at

TPTX

Turning Point Therapeutics, Inc.

Director

FPRX

FIVE PRIME THERAPEUTICS, INC.

Director

NXTC

NextCure, Inc. Healthcare

DAWN

Day One Biopharmaceuticals, Inc. Healthcare

TCRX

TScan Therapeutics, Inc. Healthcare

GAN